Gladstone NOW: The Campaign Join Us on the Journey✕
481 - 495 of 1257 Results Clear All
Benoit Bruneau and Katie Pollard study DNA folding to identify the genetic causes of congenital heart disease
Grants News Release Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab
The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders
Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab
abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab
Learn how a Gladstone bioinformatician is spending his days during shelter-in-place
Profile Bioinformatics Core Finkbeiner Lab
Jim Allison spoke along side a panel of experts in cancer immunotherapy.
Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Graduate Students and Postdocs
POZ—Finding a cure to HIV will require a full understanding of the latent reservoir, the population of cells in which the virus hides, evading antiretroviral therapy. Gladstone scientist Nadia Roan describes her recent work mapping an atlas of the reservoir, and how it provides hope that new therapies could be developed to target and eliminate reservoir cells.
Gladstone Experts HIV/AIDS Virology Roan Lab
Gladstone celebrates inspiring women in STEM
Womens Initiative Diversity
In honor of Ada Lovelace Day, Katie Pollard discusses what it’s like to be a woman in STEM and how being an outsider has helped shape her career.
Mentoring Task Force Womens Initiative Profile Data Science and Biotechnology Pollard Lab Big Data Diversity
The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.
Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab
A new series led by Gladstone, Georgia Tech, the Molecular Engineering & Sciences Institute at University of Washington, and UT Austin starts a national conversation about race and diversity in STEM fields.
Communications Elevated Voices Diversity
Doudna’s discovery of the CRISPR-Cas9 system revolutionized biomedical research
Awards News Release Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene Editing
Seth Shipman is recognized for his exceptionally creative research approach
Grants News Release Data Science and Biotechnology Shipman Lab
San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing
San Francisco Chronicle—After the president was diagnosed with COVID-19, he received aggressive medical treatment. Gladstone Senior Investigator Warner Greene noted that the combination of drugs the president received has not been tested or proven effective, and that the dexamethasone he was given is a sign his illness might be more severe than it appears.
Gladstone Experts COVID-19 Virology Greene Lab
The Guardian—Recent work from Senior Investigators Todd McDevitt, PhD, and Bruce Conklin, MD, documenting the damaging effect of SARS-CoV-2 on heart cells is mentioned in a detailed review of the long-term impact of COVID-19 on patients’ hearts.
Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab
